Pfizer Just Locked Next Growth Path: What Investors Should Know
Pfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
Which Robo Advisor Outperformed In 2026 highlights top performers and the tactics behind their gains, plus notes on risk and diversification.
24,805 articlesPfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
Cerebras burst onto the public market with a splashy IPO, but a strong first day doesn’t guarantee long-term gains. T...
Start your weekend with a clear read on the investing landscape. This Friday Reads collection distills practical idea...
P3 Health is shaping the future of value-based care with its platform. This guide breaks down what to expect from hea...
Tracking your investments effectively starts with choosing the right tool. This guide breaks down the best tools for ...
Bridgewater founder Ray Dalio warns that China’s ascent is shifting global power and investor risk. The commentary co...
Boxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
Panorama Mortgage Group is folding its various brands into a single banner, SimplyPMG, and naming Fernando Ospina as ...
While tech and AI grab headlines, other parts of the market are quietly delivering solid results. This piece explores...
Insider moves can signal confidence, but they aren’t a surebet. This guide shows you how to interpret a director purc...
Treasury yields are climbing, sending ripples through equities. This piece breaks down why rates are rising, who’s af...
Accenture says it will hire more entry-level graduates this year than last, citing a need to onboard Gen Z workers wh...